BioSpace News Archive

BioMidwest

Altitude Lab Announces First Cohort of Startups Close Over $50M in Seed Capital

Altitude Lab announced its first cohort of startups raised $54M in seed funding while incubating at Altitude Lab.

March 30, 2022
·
5 min read
Genetown

Morphic to Participate in BMO Inflammation and Immunology Spotlight Series Panel

Morphic Therapeutic today announced Morphic COO and CFO Marc Schegerin, M.D. will participate in panel discussion titled “Novel Approaches Tackling Autoimmune Conditions” at the BMO Biopharma Spotlight Series on Inflammation & Immunology on Wednesday April 6th 2022.

March 30, 2022
·
1 min read
Business

Sterotherapeutics Signs Licensing Agreement Aimed to Improve the Treatment of Multiple Myeloma

Sterotherapeutics, LLC announced today that it has entered into an exclusive agreement with Moffitt Cancer Center and Florida Atlantic University Research Corporation for a license to novel compounds and methods for the treatment of multiple myeloma.

March 30, 2022
·
2 min read
Business

Delfi Diagnostics Appoints Liz Homans to its Board of Directors

Delfi Diagnostics appointed Liz Homans, CEO of Lyell Immunopharma, Inc., to Delfi’s Board of Directors.

March 30, 2022
·
1 min read
Biotech Bay

Avinger Announces Issuance of Three New U.S. Patents in March 2022

Avinger, Inc. today announced the issuance of three new U.S. patents in March 2022 and provided an update on the expansion of its intellectual property portfolio.

March 30, 2022
·
4 min read
Ketamine Wellness Centers (KWC) Expands Treatment Options with Introduction of SPRAVATO Nasal Spray

Ketamine Wellness Centers (KWC), the largest ketamine therapy provider in the U.S. and a subsidiary of Delic Holdings Corp (“Delic” or the “Company”) (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), has expanded its treatment options to include SPRAVATO® nasal spray.

March 30, 2022
·
9 min read
BioCapital

Altoida upsizes its Series A Round to $20.3M to Advance Its First in Class AI-Powered Neurocognitive Assessment Platform

Altoida, Inc., the precision neurology company pioneering non-invasive brain health measurement and neurological disease diagnostics with AI and augmented reality (AR), today announced that it has successfully raised an additional $14 million for its Series A round with new and existing investors.

March 30, 2022
·
5 min read
Biotech Bay

Biome Introduces Next Generation Cardiovascular Performance Solution

Biome Analytics, the leading cardiovascular performance company, is pleased to introduce the Biome Opportunity Engine™.

March 30, 2022
·
3 min read
Drug Development

Concentric Analgesics Announces Positive Results from Pilot Phase 2 Clinical Trial of Vocacapsaicin in Open Laparotomy for Repair of Abdominal Ventral Hernia

Concentric Analgesics, Inc. today announced positive results from its recently completed pilot Phase 2 clinical trial of vocacapsaicin in patients undergoing open laparotomy for ventral hernia repair.

March 30, 2022
·
5 min read
BioForest

Alpine Immune Sciences to Host Virtual Investor Event at 2022 AACR Annual Meeting

Alpine Immune Sciences, Inc. today announced that Alpine will host a virtual investor event on April 12th , 2022 at 6:00pm ET.

March 30, 2022
·
4 min read